Le Lézard
Classified in: Health
Subjects: PDT, DIS, DEI

Best Christmas Gifts -- LUXATO OTC Hearing Aids


DOWNERS GROVE, Ill., Dec. 10, 2021 /PRNewswire/ -- The ongoing impact of the epidemic continues to affect the economy and daily life. LUXATO is acutely aware of the risks that everyone is facing from COVID and the needs for having reliable hearing products. Because of COVID restrictions, more and more people are drawn to shopping online. At Luxatohearing.com, they make online purchase as seamless and affordable as possible to meet everyone's needs.

The company appreciates customers' support and confidence over the years, more so during this challenging time. To compensate the effect of changes that altered everyone lifestyle, LUXATO has doubled the effort in offering hearing products that meet not only their customers' hearing needs but also to enrich their hearing experience through remote wireless entertainment.

OTC Hearing Aids

On Oct 20, 2021, the US Food and Drug Administration (FDA) published its proposed rules for a new category of over-the-counter (OTC) hearing aids in the Federal Register. Designed to make hearing aids more affordable and accessible for people with mild-to-moderate hearing loss. This proposed ruling aligns with LUXATO's primary effort, which is providing easy access to the most cost effective and high-quality products to the hearing impaired.

Buy one get one free
LUXATO wants the upcoming holiday season to be extra special, memorable, and beneficial to customers and their families. Customers will receive a gift of love -- a FREE wireless hearing device (neckband) for every purchase of our App Control hearing products. Check out this delightful offer at Luxatohearing.com.

Hearing aid with App?Price $599?

Wireless TV listening hearing aid (Free)

To fully enjoy the happiness of the Christmas holiday is to be able to hear your loved one's laughter, the heart-warming wishes and Christmas carols singing, the clinking sound of crystals and cheers during the festivity. With a few simple clicks away, LUXATO gift-wrapped hearing products are ready to join your family in rejoicing the coming holiday season.

From everyone at Luxato, Happy Holidays to you and yours!

Media contact:
Gina Yee
[email protected]
877.320.6917

SOURCE LUXATO HEARING CORP.


These press releases may also interest you

at 03:15
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
New Research by Tea Advisory Panel Reveals That Three Quarters Of Brits Never Drink Tea Before A Workout Despite It Counting Towards Fluid Intake Recommendations
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

More news about Health...


News published on and distributed by: